Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
Riboswitches01:56

Riboswitches

8.1K
Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
8.1K
RNA Interference01:23

RNA Interference

26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K
Types of RNA01:20

Types of RNA

5.8K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
5.8K
RNA Editing02:23

RNA Editing

9.0K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.0K
RNA Stability01:53

RNA Stability

33.5K
Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
33.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Visible-Light-Induced Release of Carbon Monoxide: Multifunctionally Treatment for Dry Eye Disease.

Nano letters·2026
Same author

Photosynthetic medicine: Engineering a plant-derived nanofoundry to power mammalian cells.

Cell·2026
Same author

Thermoresponsive Nanoparticles Hijack Neutrophils In Vivo to In Situ Construct Biohybrids for Enhanced Cancer and Infection Therapy.

ACS nano·2026
Same author

From materials to medicine: formulation-driven optimization and clinical prospects of NIR-II optical imaging agents.

Journal of materials chemistry. B·2026
Same author

Mucoadhesive Nanothalidomide Enema: Simultaneous Radioprotection and Barrier Repair in Radiation Enteritis Therapy.

ACS nano·2026
Same author

Modular peptide nanofibres that self-assemble on bacterial membranes overcome antimicrobial resistance.

Nature biomedical engineering·2026

Related Experiment Video

Updated: Jul 4, 2025

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells
10:02

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Published on: June 10, 2022

2.2K

Chemically Modified Platforms for Better RNA Therapeutics.

Yesi Shi1,2, Xueyan Zhen1, Yiming Zhang1

  • 1Center for Nanomedicine and Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, United States.

Chemical Reviews
|January 29, 2024
PubMed
Summary

Chemical modifications enhance RNA-based therapies by improving stability and delivery. These advancements are crucial for overcoming challenges and advancing RNA therapeutics toward clinical application.

More Related Videos

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
08:29

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

10.1K
Using In Vitro and In-cell SHAPE to Investigate Small Molecule Induced Pre-mRNA Structural Changes
11:58

Using In Vitro and In-cell SHAPE to Investigate Small Molecule Induced Pre-mRNA Structural Changes

Published on: January 30, 2019

8.3K

Related Experiment Videos

Last Updated: Jul 4, 2025

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells
10:02

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Published on: June 10, 2022

2.2K
Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
08:29

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

10.1K
Using In Vitro and In-cell SHAPE to Investigate Small Molecule Induced Pre-mRNA Structural Changes
11:58

Using In Vitro and In-cell SHAPE to Investigate Small Molecule Induced Pre-mRNA Structural Changes

Published on: January 30, 2019

8.3K

Area of Science:

  • Biomedical Science
  • Molecular Biology
  • Drug Development

Background:

  • RNA-based therapies offer significant potential for disease treatment and prevention.
  • Current RNA therapeutics face challenges like poor stability, nuclease degradation, and negative charge, limiting their clinical use.

Purpose of the Study:

  • To review chemically modified platforms for enhancing RNA-based therapeutics.
  • To analyze strategies for optimizing RNA molecule efficacy and delivery systems.
  • To highlight the impact of chemical modifications on the clinical translation of RNA drugs.

Main Methods:

  • Comprehensive review of existing literature on chemical modifications in RNA therapeutics.
  • Analysis of various chemically modified delivery platforms and their impact on RNA performance.
  • Examination of empirical studies demonstrating efficacy enhancement through chemical modifications.

Main Results:

  • Chemical modifications significantly improve RNA stability and reduce susceptibility to degradation.
  • Modified delivery vectors enhance cellular uptake and therapeutic targeting of RNA molecules.
  • Numerous studies demonstrate improved efficacy and reduced off-target effects of chemically modified RNA drugs.

Conclusions:

  • Chemical modifications are pivotal for overcoming the limitations of RNA-based therapies.
  • These modifications are essential for advancing RNA therapeutics towards broader clinical utility and effective disease management.
  • Future development should focus on innovative chemical strategies for enhanced RNA drug delivery and integration.